Understanding how influenza viruses change to evade the immune system
Dissecting the viral and host constraints that govern influenza virus antigenic evolution
This study is looking at how the flu virus changes to avoid our immune system, which can help us understand how to make better vaccines for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10993584 on NIH RePORTER |
What this research studies
This research investigates how seasonal influenza A viruses evolve to escape the immune response in humans. By examining the genetic and functional constraints that influence the virus's ability to mutate, the study aims to identify the specific pathways that these viruses take to resist vaccination efforts. The researchers will employ both laboratory experiments and animal models to explore these mechanisms, which could lead to better predictions of viral evolution and improved vaccine strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not affected by influenza or those who have already developed strong immunity to the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that better protect against evolving strains of the virus.
How similar studies have performed: Previous research has shown success in understanding viral evolution and its implications for vaccine development, suggesting that this approach could yield valuable insights.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Brooke, Christopher Byron — University of Illinois at Urbana-Champaign
- Study coordinator: Brooke, Christopher Byron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.